Intent to Sole Source - BD FACSCanto II instrument
Open Special Notice Posted
- Solicitation number
- NOI-OLAO-CC-27-000233
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Place of performance
- Bethesda, Maryland 20892, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health, Clinical Center issued a notice of intent to sole-source a one-year service agreement for BD FACSCanto II flow cytometer maintenance and support with BD Biosciences, effective November 1, 2026, with capability statement responses due by 12:00 PM Eastern time on October 23, 2026.
The sole-source determination rests on 41 U.S.C. 253(c)(1) — only one responsible source and no other supply of service will satisfy agency requirements — because BD Biosciences is the manufacturer and holds specialized expertise for this instrument. The service agreement covers two preventive maintenance inspections annually with PM kits, one business day guaranteed response for emergency on-site service, unlimited Monday through Friday service visits, software revisions released during the contract period, and telephone support for instrument, reagent, and application issues. The contract does not include on-site workstation printer repair services. Travel expenses and parts (excluding consumables) are included in the scope.
Interested vendors may submit capability statements by email to valerie.gregorio@nih.gov with subject line NOI-OLAO-CC-27-000233. The government retains sole discretion to determine whether to compete this requirement based on responses received. This is not a request for proposal; all responsible sources that could provide the required services may submit a statement for consideration.
Notice text
This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: BD Biosciences.
Acquisition Description:
Flow cytometry is a critical technology used for immunophenotyping, cellular analysis, and functional assessment of immune cells in both clinical and research settings. Our laboratory’s BD FACSCanto™ II flow cytometer has been in service for an extended period and requires routine preventive maintenance and timely technical support to ensure reliable operation and minimize downtime.
BD Biosciences is the manufacturer of the BD™ flow cytometry system and provides specialized maintenance services, technical expertise, and support specific to this system. The annual service agreement includes two preventive maintenance inspections and PM kits, one business day guaranteed response for emergency on-site service, unlimited service visits, software revisions released during the agreement period, and telephone support for instrument, reagents and application issues.
The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-OLAO-CC-27-000233) by 12:00 PM eastern standard time on 10/23/2026 to: valerie.gregorio@nih.gov.
All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
Files
| File | Type | Posted |
|---|---|---|
| Statement of Work for BD-service contract (1).docx | DOCX document |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity